Skip to main content
. 2020 Jun 25;12(6):1692. doi: 10.3390/cancers12061692

Table 2.

The top 10 DE cfmiRs in male (M) versus female (F) in normal donors’ plasma (A) and serum (B) samples.

(A) Plasma (B) Serum
Probe FC M vs. F Adjusted P-value Probe FC M vs. F Adjusted p-Value
miR-451a 2.29 2.94 × 10−5 miR-143-5p 1.34 1.50 × 10−3
miR-150-5p 1.84 1.10 × 10−3 miR-3943 1.45 2.20 × 10−3
miR-6796-3p 1.45 1.90 × 10−3 miR-8071 1.45 2.80 × 10−3
miR-4726-3p 1.37 2.00 × 10−3 miR-4746-5p 1.38 3.30 × 10−3
miR-3940-5p 1.59 2.00 × 10−3 miR-217 1.38 3.30 × 10−3
miR-3155b 1.42 2.10 × 10−3 miR-4758-5p −1.33 4.40 × 10−3
miR-6798-5p 1.61 2.10 × 10−3 miR-6787-5p 1.38 4.40 × 10−3
miR-486-5p 1.70 2.10 × 10−3 miR-34b-3p 1.34 5.20 × 10−3
miR-3912-5p 1.39 2.50 × 10−3 miR-4522 1.42 5.20 × 10−3
miR-6789-3p 1.30 2.70 × 10−3 miR-193a-3p 1.43 5.20 × 10−3

DE = differentially expressed. CfmiRs = cell-free microRNAs. M =male. F = Female. FC = fold-change.